BridgeMD
New treatment option for Sickle Cell Disease
Official title Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease
ClinicalTrials.gov ID: NCT03786549
What this study is testing
- What it's testing
- Background The pediatric-adult care transition is a risk-disrupting time for patients with chronic disease. This care transition takes place during adolescence; a period of psychological upheavals and adaptations of family roles.
- Time commitment: about 24 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 17
You may be able to join if
- For patients :
- Age: 16-17 years,
- With major sickle cell syndrome, defined by hemoglobinopathy of homozygosity SS, or double heterozygosity SC or Sβ-thalassemia,
- Benefiting from social insurance of the type "Affection of long duration" (ALD). For family members :
- Included children's parents or legal representatives,
You likely can't join if
- Presenting a cognitive or psychiatric disorder known and major that may hinder interventions or evaluation, the judgment of the investigator, and /...
- Cured of SCD by an allograft of hematopoietic stem cells.
See the full eligibility criteria
- For patients :
- Age: 16-17 years,
- With major sickle cell syndrome, defined by hemoglobinopathy of homozygosity SS, or double heterozygosity SC or Sβ-thalassemia,
- Benefiting from social insurance of the type "Affection of long duration" (ALD). For family members :
- Included children's parents or legal representatives,
- Accepting to participate in the study and having signed the informed consent.
- Presenting a cognitive or psychiatric disorder known and major that may hinder interventions or evaluation, the judgment of the investigator, and / or having a family history with this type of disorders,
- Cured of SCD by an allograft of hematopoietic stem cells.
The study team makes the final eligibility decision.
Where it's taking place
- Fort-de-France-La Martinique, La Martinique, France
- Créteil, France
- Le Kremlin-Bicêtre, France
- Lyon, France
- Paris, France
- Pontoise, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fort-de-France-La Martinique, La Martinique, France; Créteil, France; Le Kremlin-Bicêtre, France; Lyon, France; Paris, France; Pontoise, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.